These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30959235)

  • 41. Associations Among Obesity, Inflammation, and Tryptophan Catabolism in Pregnancy.
    Groer M; Fuchs D; Duffy A; Louis-Jacques A; D'Agata A; Postolache TT
    Biol Res Nurs; 2018 May; 20(3):284-291. PubMed ID: 29141444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exercise affects symptom severity but not biological measures in depression and somatization - results on IL-6, neopterin, tryptophan, kynurenine and 5-HIAA.
    Hennings A; Schwarz MJ; Riemer S; Stapf TM; Selberdinger VB; Rief W
    Psychiatry Res; 2013 Dec; 210(3):925-33. PubMed ID: 24140252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome.
    Mangge H; Summers KL; Meinitzer A; Zelzer S; Almer G; Prassl R; Schnedl WJ; Reininghaus E; Paulmichl K; Weghuber D; Fuchs D
    Obesity (Silver Spring); 2014 Jan; 22(1):195-201. PubMed ID: 23625535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychosocial stress and inflammation driving tryptophan breakdown in children and adolescents: A cross-sectional analysis of two cohorts.
    Michels N; Clarke G; Olavarria-Ramirez L; Gómez-Martínez S; Díaz LE; Marcos A; Widhalm K; Carvalho LA
    Psychoneuroendocrinology; 2018 Aug; 94():104-111. PubMed ID: 29775873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.
    Sorgdrager FJH; Doornbos B; Penninx BWJH; de Jonge P; Kema IP
    J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy.
    Pertl MM; Hevey D; Boyle NT; Hughes MM; Collier S; O'Dwyer AM; Harkin A; Kennedy MJ; Connor TJ
    Brain Behav Immun; 2013 Nov; 34():108-19. PubMed ID: 23928287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurotransmitter and monoaminergic amino acid precursor levels in rat brain: effects of chronic renal failure and of malnutrition.
    Schmid G; Bahner U; Peschkes J; Heidland A
    Miner Electrolyte Metab; 1996; 22(1-3):115-8. PubMed ID: 8676800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis.
    Georgin-Lavialle S; Moura DS; Salvador A; Chauvet-Gelinier JC; Launay JM; Damaj G; Côté F; Soucié E; Chandesris MO; Barète S; Grandpeix-Guyodo C; Bachmeyer C; Alyanakian MA; Aouba A; Lortholary O; Dubreuil P; Teyssier JR; Trojak B; Haffen E; Vandel P; Bonin B; ; Hermine O; Gaillard R
    Mol Psychiatry; 2016 Nov; 21(11):1511-1516. PubMed ID: 26809839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tetrahydrobiopterin treatment reduces brain L-Phe but only partially improves serotonin in hyperphenylalaninemic ENU1/2 mice.
    Scherer T; Allegri G; Sarkissian CN; Ying M; Grisch-Chan HM; Rassi A; Winn SR; Harding CO; Martinez A; Thöny B
    J Inherit Metab Dis; 2018 Jul; 41(4):709-718. PubMed ID: 29520738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anxiety and depression in Nepal: prevalence, comorbidity and associations.
    Risal A; Manandhar K; Linde M; Steiner TJ; Holen A
    BMC Psychiatry; 2016 Apr; 16():102. PubMed ID: 27075664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors.
    Ploder M; Spittler A; Schroecksnadel K; Neurauter G; Pelinka LE; Roth E; Fuchs D
    Clin Sci (Lond); 2009 Apr; 116(7):593-8. PubMed ID: 18986303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
    Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
    PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease.
    Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
    Atherosclerosis; 2009 May; 204(1):309-14. PubMed ID: 18823890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of Exhaustive Aerobic Exercise on Tryptophan-Kynurenine Metabolism in Trained Athletes.
    Strasser B; Geiger D; Schauer M; Gatterer H; Burtscher M; Fuchs D
    PLoS One; 2016; 11(4):e0153617. PubMed ID: 27124720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys.
    Scott KM; Bruffaerts R; Tsang A; Ormel J; Alonso J; Angermeyer MC; Benjet C; Bromet E; de Girolamo G; de Graaf R; Gasquet I; Gureje O; Haro JM; He Y; Kessler RC; Levinson D; Mneimneh ZN; Oakley Browne MA; Posada-Villa J; Stein DJ; Takeshima T; Von Korff M
    J Affect Disord; 2007 Nov; 103(1-3):113-20. PubMed ID: 17292480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Depression and anxiety symptoms in cardiac patients: a cross-sectional hospital-based study in a Palestinian population.
    Allabadi H; Alkaiyat A; Alkhayyat A; Hammoudi A; Odeh H; Shtayeh J; Taha M; Schindler C; Zemp E; Haj-Yahia S; Probst-Hensch N
    BMC Public Health; 2019 Feb; 19(1):232. PubMed ID: 30808333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA).
    Duivis HE; Vogelzangs N; Kupper N; de Jonge P; Penninx BW
    Psychoneuroendocrinology; 2013 Sep; 38(9):1573-85. PubMed ID: 23399050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation.
    Hughes MM; Carballedo A; McLoughlin DM; Amico F; Harkin A; Frodl T; Connor TJ
    Brain Behav Immun; 2012 Aug; 26(6):979-87. PubMed ID: 22683764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.